FDA approves $84,000 a treatment hepatitis C drug

Posted on December 17, 2013 By RxStrategies, Inc. - Media

By Associated Press

Posted: December 7, 2013 – 9:30 am ET

Tags: Associated Press (AP), Pharmaceuticals, Physicians, U.S. Food and Drug Administration (FDA)

U.S. health officials have approved a highly anticipated hepatitis C drug from Gilead Sciences that is expected to offer a faster, more palatable cure to millions of people infected with the liver-destroying virus.

The Food and Drug Administration said Friday it approved the pill Sovaldi in combination with older drugs to treat the main forms of hepatitis C that affect U.S. patients.